MEDNAX Announces Acquisition of Anesthesiology Practice in North Carolina
23 Marzo 2015 - 5:00AM
Business Wire
MEDNAX, Inc. (NYSE: MD), today announced the acquisition of
Mosaic Anesthesia & Perioperative Services, P.C., a private
physician group practice based in New Bern, N.C. At closing, the
practice became part of MEDNAX’s American Anesthesiology
division.
Physicians with Mosaic Anesthesia & Perioperative Services
have been providing anesthesia services in New Bern and surrounding
areas since 1982. The practice employs 15 anesthesiologists that
work as part of a care team model including anesthetists at
CarolinaEast Medical Center in New Bern and its affiliated
ambulatory surgery center, as well as Carteret General Hospital in
Morehead City, Columbus Regional Healthcare System in Whiteville
and Lenoir Memorial Hospital in Kinston. The practice’s anesthesia
services include general anesthesia, neurosurgery (including
spine), cardiac, orthopedic, vascular, obstetric, gynecologic and
ear, nose and throat (ENT).
“Partnering with MEDNAX presents an opportunity for us to have
long-term stability in the marketplace and to be part of a proven
business model that will keep us on the forefront of high quality
anesthesia care,” said Bill Panza, M.D., who will serve as medical
director for the practice. “Not only will MEDNAX provide business
leadership, administrative support and access to a nationwide
network of our peers, but the company’s longstanding commitment to
research, education and clinical quality will support our goals for
improved outcomes and patient satisfaction.”
MEDNAX’s American Anesthesiology division consists of more than
2,400 anesthesia providers, including more than 975 physicians and
1,425 anesthetists practicing in 13 states.
This was a cash transaction, and it is expected to be
immediately accretive to earnings. No additional terms of the
transaction were disclosed.
ABOUT MEDNAX
MEDNAX, Inc. is a national medical group comprised of the
nation's leading providers of neonatal, anesthesia, maternal-fetal
and pediatric physician subspecialty services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping
the delivery of care within their specialties and subspecialties,
using evidence-based tools, continuous quality initiatives and
clinical research to enhance patient outcomes and provide
high-quality, cost-effective care. Pediatrix Medical Group, a
division of MEDNAX, was founded in 1979 and includes neonatal
physicians who provide services at more than 370 neonatal intensive
care units, and collaborate with affiliated maternal-fetal
medicine, pediatric cardiology, pediatric critical care and other
physician subspecialists to provide a clinical care continuum.
Pediatrix is also the nation's largest provider of newborn hearing
screens. American Anesthesiology, a division of MEDNAX, was
established in 2007 and includes more than 2,400 anesthesiologists
and advanced practitioners who provide anesthesia care to patients
in connection with surgical and other procedures as well as pain
management. MEDNAX, through its affiliated professional
corporations, employs more than 2,650 physicians in 34 states and
Puerto Rico. Additional information is available at
www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-looking
statements may include, but are not limited to, statements relating
to our objectives, plans and strategies, and all statements, other
than statements of historical facts, that address activities,
events or developments that we intend, expect, project, believe or
anticipate will or may occur in the future. These statements are
often characterized by terminology such as “believe”, “hope”,
“may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”,
“estimate”, “project”, “positioned”, “strategy” and similar
expressions, and are based on assumptions and assessments made by
MEDNAX’s management in light of their experience and their
perception of historical trends, current conditions, expected
future developments and other factors they believe to be
appropriate. Any forward-looking statements in this press release
are made as of the date hereof, and MEDNAX undertakes no duty to
update or revise any such statements, whether as a result of new
information, future events or otherwise. Forward-looking statements
are not guarantees of future performance and are subject to risks
and uncertainties. Important factors that could cause actual
results, developments, and business decisions to differ materially
from forward-looking statements are described in MEDNAX’s most
recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well
MEDNAX’s current reports on Form 8-K, filed with the Securities and
Exchange Commission.
MEDNAX, Inc.Charles Lynch, 954-384-0175, x 5692Vice President,
Strategy and Investor Relationscharles_lynch@mednax.com
MacDonald, Dettwiler & (NYSE:MDA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
MacDonald, Dettwiler & (NYSE:MDA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024